← Leaderboards
Victor A Kovalenko
Immunetics, Inc.
$2,509,312
Attributed
$2,509,312
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$2,509,312 · 4
By mechanism
R44$1,773,110 · 2
R43$736,202 · 2
Top collaborators
No co-investigators on record.
Most similar at Immunetics, Inc.
Same institution · by research overlap
- Andrew E. Levin$41,764,391
- Neil X Krueger$5,735,933
Others in their field
Top investigators on “Whole Blood”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Michael A Province · Washington University$60,087,610
- Richard Gibbs · Baylor College Of Medicine$53,550,246
- Richard A Gibbs · Baylor College Of Medicine$50,963,880
- Stacey Gabriel · Massachusetts Institute Of Technology$45,704,104
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$40,286,824
Research focus
Whole BloodAntibodiesSerodiagnosesTechnologySerumDiagnosticReagentSensitivity And SpecificityLateralStagingDiagnostic TestsPerformanceAntigensBaseDetectionEnzyme-Linked Immunosorbent AssaySamplingCostPlasmaPoint Of CareBedside TestingsPhysiciansPublic Health RelevanceChemistry
Grant awards (6)
Rapid point of care test for Lyme serodiagnosis based on novel ultra sensitive de$1,000,000
R44 · FY2014 · AI · contact PI
Rapid point of-care test for Lyme serodiagnosis based on novel ultra-sensitive de$300,000
R43 · FY2011 · AI · contact PI
Rapid point of-care test for Lyme serodiagnosis based on novel ultra-sensitive de$300,000
R43 · FY2010 · AI · contact PI
Peptide-Based Serological Test for Cysticercosis$328,109
R44 · FY2007 · AI · contact PI
Peptide-Based Serological Test for Cysticercosis$445,001
R44 · FY2006 · AI · contact PI
Peptide-Based Serodiagnostic Test for Cysticercosis$136,202
R43 · FY2005 · AI